ALAN G. ROBINSON, M.D.; PAUL B. NELSON, M.D.
Since prolactin was shown by Kleinberg and Frantz (1) to be a hormone separate from human growth hormone and since the development of radioimmunoassays for prolactin (2), the diagnosis of hyperprolactinemia as a cause of galactorrhea and amenorrhea has become common. Among unscreened women with amenorrhea, 15% to 25% may have elevated levels of prolactin; if one preselects for galactorrhea, the incidence is even higher (3).
Normally prolactin is under chronic suppression by dopamine, released from the hypothalamus. Prolactin secretion can be inhibited by pharmacologic agents that mimic the effect of dopamine (levodopa, bromocriptine, pergolide mesylate), and stimulated by direct
Learn more about subscription options.
Register Now for a free account.
ROBINSON AG, NELSON PB. Prolactinomas in Women: Current Therapies. Ann Intern Med. 1983;99:115–118. doi: 10.7326/0003-4819-99-1-115
Download citation file:
Published: Ann Intern Med. 1983;99(1):115-118.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only